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Introduction
Implantable cardioverter-defibrillator (ICD) therapy is acknowledged 
as a valid treatment method for the effective prevention of sudden 
cardiac death.1) Sudden cardiac death is a major cause of mortality 
(19–26%) in adult congenital heart disease (ACHD) patients.2) Since the 
survival rate of patients with congenital heart disease has risen due to 
improved surgical methods and peri-operative management, the 
number of ACHD patients has also increased recently. Consequently, 
the importance of the proper management of long term complications 
in these patients has garnered attention. Therefore, the need of ICD 
therapy in ACHD patients is gaining momentum.3) We report a case in 
which an ICD was transvascularly implanted in a patient who had 
undergone a one-and-a-half ventricle repair. 
Case
A 31-year-old male patient presented to the emergency 
department with symptoms including severe palpitation and a 
presyncopal episode. His blood pressure was 80/60 mm Hg and the 
electrocardiogram showed monomorphic ventricular tachycardia 
(VT), at a rate of 225 bpm (Fig. 1). In the emergency department, 
cardioversion was performed and the tachycardia was converted 
into a sinus rhythm.
The patient was diagnosed with right heart failure at the age of 
10, when he visited our clinic due to dyspnea on exertion and 
generalized edema. The patient was followed up in the outpatient 
clinic regularly with heart failure medications. However, right 
ventricular (RV) dysfunction occurred and RV enlargement 
progressed. Because the severe RV dysfunction was unresponsive to 
medical treatment, the patient underwent a one-and-a-half ventricle 
repair along with tricuspid annuloplasty and valvuloplasty. One-and-
a-half ventricle repair is an operation to create an end-to-side 
anastomosis of the superior vena cava (SVC) and the right 
pulmonary artery (a bidirectional cavopulmonary shunt) in 
conjunction with standard heart repair. A partial diversion of 
systemic venous return directly to the pulmonary artery reduces the 
volume load on the right ventricle. The schematic picture for 
describing the one-and-a-half ventricle repair was drawn on the 
patient’s chest X-ray (Fig. 2A). After the one-and-a-half ventricle 
repair, the patient’s symptoms improved dramatically and, against 
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our advice, he stopped visiting the clinic.
The echocardiogram performed at the age of 31 still showed 
severe RV enlargement with RV dyskinesia. Tricuspid valve 
regurgitation was improved compared with that before the 
operation. The connection between the SVC and the pulmonary 
artery created during the surgical procedure was intact. To better 
assess RV function, a heart magnetic resonance image (MRI) was 
performed. The heart MRI showed marked RV enlargement, 
dyskiensia, wall thinning, and extensive delayed hyperenhancement, 
indicative of fibrous displacement (Fig. 3). These MRI findings met 
the criteria for a diagnosis of arrhythmogenic RV cardiomyopathy 
(ARVC). The patient had a hemodynamically unstable VT due to 
ARVC, which was caused by the severe RV dysplasia and 
dysfunction, and the decision to insert the single-chamber ICD was 
made. The ICD could not be transvenously implanted in the 
conventional manner, because the SVC was connected to the 
pulmonary artery. We decided to use the transvascular approach 
through the right axillary vein to implant the ICD. We first threaded 
Fig. 1. Patient’s ECG when he visited the emergency department with palpitations and pre-syncope. ECG showed monomorphic ventricular tachycardia at 
the rate of 225 bpm. ECG: electrocardiogram.
Fig. 2. A schematic picture describing the one-and-a-half ventricle repair and chest X-ray image of the implanted ICD. A: a schematic picture describing 
the one-and-a-half ventricle repair is drawn on the patient’s chest X-ray. Gray arrows represent the blood flow. B: the chest X-ray shows that the ICD is 
placed in the right pectoral area in the RV via the cavopulmonary shunt. ICD: implantable cardioverter-defibrillator, PA: pulmonary artery, RV: right 
ventricle, SVC: superior vena cava.
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a catheter through the femoral vein and performed a right 
subclavian vein angiogram to confirm an intact flow through the 
connection between the SVC and the pulmonary artery. The right 
axillary vein was punctured. A long wire was smoothly passed 
through subclavian vein, SVC, cavopulmonary shunt, pulmonary 
artery, and pulmonic valve sequentially, ultimately reaching the RV. A 
long peel-away sheath was introduced following the long wire and a 
screw type ICD lead (DURATA 7120Q 65 cm, St. Jude Medical, Valley 
View Court Sylmar, CA, USA) was inserted within the RV. The ICD 
lead was first placed at the RV apex, as in the conventional manner, 
and was stably anchored. However, the electrophysiologic properties 
were not adequate, and thus no signal was captured. Hence, the ICD 
lead was repositioned at the anteroseptal junction, where the RV 
electrical signal was satisfactory. The ICD lead was stably anchored 
at that position. The ICD generator (Ellipse VR, St. Jude Medical, Valley 
View Court Sylmar, CA, USA) was placed at the right pectoral area 
and we sutured the wound and finished the procedure. After the 
procedure, we performed an ICD interrogation and defibrillation 
threshold test. The defibrillation threshold was 10 joules, and the R 
wave amplitude, pacing threshold and impedance were 7.0 mV, 0.6 
V at 0.5 ms, and 550 ohms, respectively. On the last outpatient clinic 
follow-up, the implanted ICD lead was in a stable position (Fig. 2B) 
and normal pulmonic valve function was noted.
Discussion
Up until now, ICD insertion was not possible by the conventional 
transvascular approach in patients diagnosed with congenital and 
structural heart disease that underwent palliative surgery resulting 
in hemodynamically normal heart.4)5) In these patients, ICD 
implantation can be performed occasionally, and recently, cases 
involving groups or a single patient have been reported.6)7) Also, 
subcutaneous ICDs can be used as an alternative method in cases in 
which a normal vascular approach is not feasible.8)9) However, the 
subcutaneous ICD is not yet a commercially available treatment 
option in Korea. One-and-a-half ventricle repair is an effective 
palliative surgical method which reduces the RV volume in congenital 
heart disease patients with RV hypoplasia or dysfunction.10) In 
patients who undergo a one-and-a-half ventricle repair, fatal 
arrhythmias requiring ICD implantation could occur due to the 
underlying congenital heart disease. But, the ICD cannot be 
transvenously implanted in the conventional manner because the 
SVC is connected to the pulmonary artery in these patients. So, an 
epicardial approach has been used. The epicardial approach is an 
invasive procedure in comparison to the transvascular approach. In 
our study, we inserted an ICD in the right pectoral area using the 
transvascular approach through the right axillary vein and 
bidirectional cavopulmonary shunt in a patient who had undergone 
a one-and-a-half ventricle repair. To our knowledge, this is the 
creative method that has not been reported before.
In conclusion, we can feasibly perform single-chamber ICD 
implantation in a patient who has undergone one-and-a-half 
ventricle repair through the conventional vascular approach instead 
of the epicardial approach. This can be accepted as an effective 
treatment option.
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